Distinct T-cell receptor profiles associated with hepatitis B e antigen seroconversion during entecavir treatment.

Yi-Fan LianYing XuYu-Rong GuYan-Hua BiChun-Hong LiaoMiao-Xian ZhaoXia-Lin LiaoZhan-Hui WangHong-Kai WuYue-Hua Huang

Published in: Liver international : official journal of the International Association for the Study of the Liver (2020)

Distinct TCR profiles contribute to predicting HBeAg seroconversion in CHB patients during ETV treatment and certain TCRβ CDR3 motif may be utilized for CHB immunotherapy in the future.

Keyphrases

end stage renal disease
regulatory t cells
newly diagnosed
ejection fraction
acute lymphoblastic leukemia
prognostic factors
immune response
combination therapy